Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02357654 · ClinicalTrials.gov registry record · Phase 4
GnRH for Luteal Support in IVF/ICSI/FET Cycles
A Phase 4 study of Infertility, sponsored by University Reproductive Associates.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 350
- Enrollment target
- 1
- Study location
NCT02357654 is a Phase 4 study of Infertility that is actively recruiting participants, run by University Reproductive Associates. The registered enrollment target is 350 participants, below the 7,585-participant average among 74 other Infertility trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02357654, a Phase 4 study of Infertility, is actively recruiting participants, sponsored by University Reproductive Associates.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 350 participants
- Enrollment target
- 1
- Study location
Study Summary
During IVF cycles an embryo is generally placed into the uterine cavity between 3 and 5 days after fertilization. For a successful pregnancy to take place, that embryo must then implant in the properly primed and staged endometrium, which subsequently must continue to develop to accommodate the growing and maturing embryo and then fetus. This process is normally regulated by hormonal interactions between the fetal, endometrial and luteal tissue. It has been found that after IVF additional support for the endometrium with progesterone improves implantation and subsequent live birth rates in IVF cycle . Recent data has shown that additional supplementation with a single administration of a GnRH agonist around the time the time of embryo transfer may further enhance these rates .
Conditions Studied
Interventions
- DRUG placebo
- DRUG GnRH
Study Locations (1)
New Jersey
- University Reproductive Associates - Hasbrouck Heights
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2015-11 |
| Est. Completion | 2026-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02357654
The ClinicalTrials.gov registry entry for NCT02357654 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 350 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 7,585-participant average among 74 other Infertility trials with a reported enrollment target (95% lower). The listed sponsor is University Reproductive Associates, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Infertility appearing as the primary indexed condition, and to 2 interventions - of which placebo is the first listed.
NCT02357654 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.
Frequently Asked Questions
What is clinical trial NCT02357654 about?
NCT02357654 is a clinical study titled "GnRH for Luteal Support in IVF/ICSI/FET Cycles". During IVF cycles an embryo is generally placed into the uterine cavity between 3 and 5 days after fertilization. For a successful pregnancy to take place, that embryo must then implant in the properly primed and staged endometrium, which subsequently must continue to develop to accommodate the grow...
What is the current status of trial NCT02357654?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 350 participants. The study started on 2015-11. Estimated completion is 2026-07.
What conditions does trial NCT02357654 study?
This clinical trial studies the following conditions: Infertility.
What interventions are being tested in trial NCT02357654?
The interventions under investigation include: placebo (DRUG), GnRH (DRUG).
Who is sponsoring clinical trial NCT02357654?
This trial is sponsored by University Reproductive Associates, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02357654 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Infertility
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Randomized Controlled Trial of Combined Letrozole and Clomid (CLC II) Versus Letrozole Alone for Women With Anovulation
ACTIVE NOT RECRUITING · Phase 4
-
Endometrial Markers and Response of Endometriosis Patients to Prolonged GnRH Agonist Prior to IVF
COMPLETED · Phase 4
-
Vaginal Compared to Intramuscular Progesterone for Frozen Embryo Transfer
COMPLETED · Phase 4
-
Concomitant Administration of FSH With HCG Improves Oocyte Maturation and Quality Double -Blinded Randomized Trial
COMPLETED · Phase 4
-
Menopur Mixed Protocol
COMPLETED · Phase 4
-
Gamete Treatment to Correct Fertilization Failure
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.